Reampla Trademark Details

Reampla was registered on Tuesday, April 14, 2009 and is currently owned by Pfizer Inc. under the registration number 3607670 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 8 years ago on Friday, November 20, 2015, according to the United State Patent & Trademark Office
Word Mark Reampla
Status Dead Registered 710 — Cancelled - Section 8
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Serial Number 78808402
Registration Number 3607670
Status Date Friday, November 20, 2015
Filing Date Friday, November 20, 2015
Registration Date Tuesday, April 14, 2009
Attorney Cindy M. Zelson

Correspondent

Cindy M. Zelson
Pfizer Inc.
150 E. 42nd Street, 5th Floor
Legal Division - Mailstop 150/5/49
New York NY 10017

Case File Statements

Goods & Services Pharmaceutical preparations for the treatment of cancer

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, November 20, 2015
First Use Anywhere Thursday, December 11, 2008
First Use In Commerce Thursday, December 11, 2008
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.